As of 2025-11-16, the Relative Valuation of Utah Medical Products Inc (UTMD) is 124.70 USD. This relative valuation is based on P/E multiples. With the latest stock price at 55.38 USD, the upside of Utah Medical Products Inc based on Relative Valuation is 125.2%.
The range of the Relative Valuation is 101.73 - 142.36 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.6x - 36.4x | 35.2x |
| Forward P/E multiples | 26.9x - 30.3x | 29.5x |
| Fair Price | 101.73 - 142.36 | 124.70 |
| Upside | 83.7% - 157.1% | 125.2% |
| Date | P/E |
| 2025-11-14 | 14.16 |
| 2025-11-13 | 14.35 |
| 2025-11-12 | 14.37 |
| 2025-11-11 | 14.63 |
| 2025-11-10 | 14.65 |
| 2025-11-07 | 14.68 |
| 2025-11-06 | 14.80 |
| 2025-11-05 | 14.83 |
| 2025-11-04 | 14.89 |
| 2025-11-03 | 14.96 |
| 2025-10-31 | 14.86 |
| 2025-10-30 | 14.47 |
| 2025-10-29 | 14.58 |
| 2025-10-28 | 14.97 |
| 2025-10-27 | 15.14 |
| 2025-10-24 | 15.45 |
| 2025-10-23 | 15.46 |
| 2025-10-22 | 15.60 |
| 2025-10-21 | 15.46 |
| 2025-10-20 | 15.54 |
| 2025-10-17 | 15.20 |
| 2025-10-16 | 15.36 |
| 2025-10-15 | 15.46 |
| 2025-10-14 | 15.38 |
| 2025-10-13 | 15.48 |
| 2025-10-10 | 15.68 |
| 2025-10-09 | 16.09 |
| 2025-10-08 | 16.22 |
| 2025-10-07 | 16.17 |
| 2025-10-06 | 16.04 |
| 2025-10-03 | 16.19 |
| 2025-10-02 | 16.33 |
| 2025-10-01 | 16.29 |
| 2025-09-30 | 16.10 |
| 2025-09-29 | 16.04 |
| 2025-09-26 | 16.06 |
| 2025-09-25 | 15.97 |
| 2025-09-24 | 16.08 |
| 2025-09-23 | 16.11 |
| 2025-09-22 | 16.18 |
| 2025-09-19 | 15.90 |
| 2025-09-18 | 16.22 |
| 2025-09-17 | 15.81 |
| 2025-09-16 | 15.98 |
| 2025-09-15 | 15.98 |
| 2025-09-12 | 15.93 |
| 2025-09-11 | 15.99 |
| 2025-09-10 | 15.54 |
| 2025-09-09 | 16.06 |
| 2025-09-08 | 16.20 |